Hypogenitalism

from Wikipedia, the free encyclopedia
Classification according to ICD-10
Q50- Congenital malformations of the ovaries, the uterine tubes and the ligaments. lata uteri
Q51- Congenital malformations of the uterus and the cervix uteri
Q52- Other congenital malformations of the female genital organs
Q55- Other congenital malformations of the male genital organs
ICD-10 online (WHO version 2019)

As hypogenitalism ( give a wiki. Ὑπό Hypo = under ') refers to the underdevelopment of the genital organs, Latin Genitalhypoplasie , (infantile development of the genitalia), including mostly the secondary sexual characteristics are expected. The cause of hypogenitalism is mostly of a hormonal nature, for example as a result of an underfunction of the gonads (hypogonadism). The opposite of hypogenitalism is excessive sex development ( hypergenitalism ).

Clinical picture

In men, hypogenitalism manifests itself through a small child's penis (see also micropenis ) and a small, smooth scrotum . The prostate cannot be felt, or it can only be felt as a hazelnut-sized lump. In women, in the case of hypogenitalism, the development of the uterus and fallopian tubes is disturbed. In both sexes, the secondary sexual characteristics are incomplete.

Underdeveloped sexual organ in a man

Hypogenitalism as a symptom / in syndromes

In many cases, hypogenitalism is a symptom of various diseases and syndromes . These include:

therapy

Hypogenitalism can be treated with hormone therapy . In male patients, for example, testosterone is administered in the form of injections or as a patch ( testosterone patch ). In female patients, depending on age and degree of hypogenitalism, ethinylestradiol , estradiol or chlormadinone are usually given. In the case of Klinefelter syndrome, for example, the administration of testosterone improves the quality of life of the patient and is effective against anemia , osteoporosis , muscle weakness and impotence .

Individual evidence

  1. a b H. Vogl: Differential diagnosis of the medical-clinical symptoms. UTB-Verlag, 1994, ISBN 3-8252-8066-7 restricted preview in the Google book search
  2. Bernfried Leiber (founder): The clinical syndromes. Syndromes, sequences and symptom complexes . Ed .: G. Burg, J. Kunze, D. Pongratz, PG Scheurlen, A. Schinzel, J. Spranger. 7., completely reworked. Edition. tape 2 : symptoms . Urban & Schwarzenberg, Munich et al. 1990, ISBN 3-541-01727-9 .
  3. ^ SA Temtamy, NA Meguid: Hypogenitalism in the acrocallosal syndrome. In: Am J Med Genet , 32, 1989, pp. 301-305. PMID 2658583
  4. Biemond Syndrome II.  In: Online Mendelian Inheritance in Man . (English), accessed February 19, 2010.
  5. E. Tarhan et al. a .: The carpenter syndrome phenotype In: Int J Pediatr Otorhinolaryngol , 68, 2004, pp. 353-357. PMID 15129947
  6. Charge Syndrome.  In: Online Mendelian Inheritance in Man . (English); Retrieved February 19, 2010.
  7. A. Schinzel: Down Syndrome - Trisomy 21. Institute for Medical Genetics of the University of Zurich. 1/2007
  8. Harrod Syndrome.  In: Online Mendelian Inheritance in Man . (English); Retrieved February 19, 2010.
  9. Orpha.net: Prominent Glabella - Microcephaly - Hypogenitalism. Retrieved February 19, 2010
  10. Martsolf Syndrome.  In: Online Mendelian Inheritance in Man . (English), accessed February 19, 2010.
  11. Orpha.net: MEHMO syndrome. Retrieved February 19, 2010.
  12. Robinow Syndrome, autosomal recessive.  In: Online Mendelian Inheritance in Man . (English); Retrieved February 19, 2010.
  13. Ulnar-Mammary Syndrome; UMS.  In: Online Mendelian Inheritance in Man . (English), accessed February 19, 2010.
  14. ^ Warburg Micro Syndrome; WARBM.  In: Online Mendelian Inheritance in Man . (English); Retrieved February 19, 2010.
  15. E. Weimann and G. Horneff: Endocrinological and immunological disease pictures in pediatrics. Schattauer Verlag, 2002, ISBN 3-7945-2105-6 , pp. 44-49. limited preview in Google Book search
  16. M. Zitzmann et al. a .: X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. In: J Clin Endocrinol Metab , 89, 2004, pp. 6208-6217. PMID 15579779
  17. A. Kübler et al. a .: The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome. In: Exp Clin Endocrinol , 100, pp. 1992, pp. 129-132. PMID 1305064
  18. J. Nielsen et al. a .: Follow-up of 30 Klinefelter males treated with testosterone. In: Clin Genet 33, 1988, pp. 262-269. PMID 3359683
  19. A. Bade: The Klinefelter Syndrome: Consideration in medical practice and literature. Dissertation, Westfälische Wilhelms-Universität Münster, 2007